[Bio-Medical/Healthcare]
MediWhale
-
Desired form of investment :
VC investment(series-A)
-
Year of establishment : 2016
-
Providing a basis for preventive treatment by accurately predicting the risk of future cardiovascular diseases through a simple eye examination.
CEO: Choi Tae-geun
Number of employees : 8
Business Structure : B2B / B2G
Market : Medical device
Key Technology : AI software
Website : https://www.mediwhale.com
Reason to Invest(Our Product & Service)
1. Reti-CVD : See all your CVD risk for having a cardiovascular event using a retinal image
2. Reti-CKD : Measure your chronic kidney disease risk score better than a urinalysis or blood test
3. Reti-Eye : Reti-eye independently checks your retinal photographs and provides decision support on whether to refer to an ophthalmologist
4. Reti-Age : Find your biological age based on your retina photographs
Our Achievement
2022. 08 : Reti-CVD was approved as a class III medical device by the Ministry of Food and Drug Safety of Korea
2022. 06 : Reti-Eye was installed in Cheonho public health clinic in Seoul as part of a metabolic disease prevention campaign
2022. 04 : Retinal photograph-based deep learning predicts biological age, and stratifies morbidity and mortality risk” was published in the peer-reviewed medical journal,
Age and Ageing (IF:12.8)
Reti-Eye & Reti-CVD were registered as class IIa medical devices by the National Agency of Drug and Food Control (NA-DFC) of Indonesia – Category: Cardiovascular
risk assessment based on retinal image & eye screening service
2022. 02 : Singapore office was opened
Reti-Eye & Reti-CVD were registered as a medical device by Medicines and Healthcare products Regulatory Agency of UK – Category: Cardiovascular risk
assessment based on retinal image & eye screening service
2022. 01 : Reti-Eye was registered as a medical device by the Health Science Authority (HSA) of Singapore – Category:
Cardiovascular risk assessment based on retinal image & eye screening service
Inquiry
Want more information about this company? Leave a message and we will contact you.
We recognize the importance of privacy and confidentiality of personal information.
We protect and use personal information about you in limited scope by
Korea Personal Information Act and our
Privacy Policy.
If you have read and agreed to our privacy policy, check the boxes and
click "Send" button.